Tamar Ben-Yedidia

This inventor holds 10 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents. Top assignees: Yeda Research and Develpment & Co. Ltd, Biondvax Pharmaceuticals Ltd., The Weizmann Institute of Science. Active years: 2004-2016.

USPTO Granted Patents = 10

% Patents Active = 30.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 91(Granted Patents)

Company Filing History:

6 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

3 out of 4

Biondvax Pharmaceuticals Ltd.

patents

1 out of 49

The Weizmann Institute of Science

patents

Years Active: 2004-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9353159 - Multimeric multiepitope influenza vaccines (2016-05-31),

2. 9303070 - Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines (2016-04-05),

3. 9029526 - Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection (2015-05-12),

4. 8747861 - Multimeric multiepitope influenza vaccines (2014-06-10),

5. 8357789 - Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection (2013-01-22),

6. 7914797 - Influenza vaccine (2011-03-29),

7. 7786279 - Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection (2010-08-31),

8. 7514086 - Peptide-based vaccine for influenza (2009-04-07),

9. 7192595 - Peptide-based vaccine for influenza (2007-03-20),

10. 6740325 - Peptide-based vaccine for influenza (2004-05-25),

Title: Tamar Ben-Yedidia: Innovator in Influenza Vaccine Development

Introduction

Tamar Ben-Yedidia is a prominent inventor based in Mazkeret Batya, Israel. She has made significant contributions to the field of immunology, particularly in the development of innovative influenza vaccines. With a total of 10 patents to her name, her work has the potential to impact public health on a global scale.

Latest Patents

Among her latest patents is the invention of multimeric multiepitope influenza vaccines. This patent describes an isolated polynucleotide encoding an influenza multi-epitope polypeptide, which comprises multiple copies of various influenza virus peptide epitopes. The polypeptide is designed to enhance the immune response against influenza. Another notable patent focuses on multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines. This invention relates to the use of these peptide-based compositions for immunizing subjects against influenza, either prior to or alongside seasonal or pandemic vaccines.

Career Highlights

Tamar has worked with several notable companies in her career, including Yeda Research and Development Company and Biondvax Pharmaceuticals. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective vaccines.

Collaborations

Tamar has collaborated with esteemed colleagues in her field, including Ruth Arnon and Raphael Levi. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Tamar Ben-Yedidia's work in the field of influenza vaccine development showcases her dedication to improving public health through innovative solutions. Her patents and collaborations highlight her significant contributions to immunology and the ongoing fight against influenza.